Fontenay aux Roses, France

Jean-Francedillaois Mayaux


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jean-Francedillaois Mayaux

Introduction

Jean-Francedillaois Mayaux is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of therapeutic agents and enzymatic processes, holding a total of two patents. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

One of Mayaux's latest patents is titled "Albumin derivatives with therapeutic functions." This invention utilizes albumin as a stable plasma transporter with therapeutic functions derived from a membrane receptor. It describes new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome (AIDS). The hybrid macromolecules consist of albumin derivatives coupled to derivatives of the CD4 receptor, which exhibit normal or higher affinity for the HIV-1 virus.

Another significant patent is "Enantioselective amidases and uses thereof." This invention concerns polypeptides that possess enantioselective amidase activity. It also includes the genetic material required for the expression of these polypeptides and a microbiological procedure for their preparation. The invention highlights the utilization of these polypeptides and transformed microorganisms for the enantioselective synthesis of acids from racemic amides, particularly focusing on propionic acids, especially (S)-2-aryl-propionamide.

Career Highlights

Throughout his career, Jean-Francedillaois Mayaux has worked with prominent companies such as Rhone-Poulenc, Inc. and Rhone-Poulenc Santé. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Mayaux has collaborated with notable coworkers, including Patrice Yeh and Jerome Becquart. These partnerships have likely enhanced his research and development efforts in the field of therapeutic inventions.

Conclusion

Jean-Francedillaois Mayaux is a distinguished inventor whose work in therapeutic agents and enzymatic processes has led to significant advancements in medical science. His patents reflect a commitment to addressing critical health issues through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…